← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	2,735	+59	+2%	$146B
2	2 Amgen AMGN $237B	2,197	-21	-0.9%	$106B
3	3 Eli Lilly LLY $1.13T	2,022	+73	+4%	$182B
4	4 Becton Dickinson BDX $52.5B	1,487	-35	-2%	$59.8B
5	5 Regeneron Pharmaceuticals REGN $82.3B	972	+48	+5%	$49.6B
6	6 McKesson MCK $116B	971	+1	+0.1%	$25.9B
7	7 AstraZeneca AZN $260B	772	+15	+2%	$26.1B
8	8 Conagra Brands CAG $6.81B	755	+4	+0.5%	$14.8B
9	9 Novo Nordisk NVO $174B	736	+29	+4%	$11B
10	10 ResMed RMD $33.9B	662	-1	-0.2%	$23.9B
11	11 West Pharmaceutical WST $26.9B	640	+50	+8%	$24.7B
12	12 Lamb Weston LW $7.47B	608	-11	-2%	$9.99B
13	13 DaVita DVA $11.9B	515	+24	+5%	$11.1B
14	14 DELISTED CATALENT, INC. CTLT	509	+9	+2%	$18.2B
15	15 Teva Pharmaceutical Industries Limited TEVA $48.2B	440	-11	-2%	$5.55B
16	16 Medifast MED $135M	301	+24	+9%	$2.82B
17	17 Accendra Health ACH $21.3M	260	+8	+3%	$2.92B
18	18 Herbalife HLF $1.52B	248	+4	+2%	$5.55B
19	19 Inspire Medical Systems INSP $2B	248	-3	-1%	$4.83B
20	ARNA 20 DELISTED Arena Pharmaceuticals Inc ARNA	237	+2	+0.9%	$3.87B
21	21 Opko Health OPK $1.16B	233	-6	-3%	$774M
22	22 DELISTED WW International WW	228	+10	+5%	$2.32B
23	TWNK 23 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	190	-7	-4%	$2.49B
24	24 Fresenius Medical Care FMS $11.8B	173	+6	+4%	$848M
25	25 MannKind Corp MNKD $1.01B	169	+6	+4%	$593M